GentleCure is proud to offer the non-surgical, gold-standard treatment for nonmelanoma skin cancer
Want to cure your skin cancer without surgery?
GentleCure is a gentle, surgery-free treatment that is safe and has a 99%+ cure rate in basal and squamous cell skin cancers. Treatment is done right in the dermatology office over the course of a few weeks using an advanced ImageGuided SRT machine. It is the only skin cancer treatment with ultra-sound imaging that lets you see the cancer on the screen and review the progress made throughout the course of treatment until there are no visible signs of cancer.
See what to expect with treatment
GentleCure (Image-Guided SRT) is designed to treat skin cancer without the discomfort and cosmetic issues often associated with surgery. There is no cutting, surgical scarring, or need for reconstructive surgery, and you can maintain your normal daily activities throughout treatment.
Watch our short video
Learn more about the treatment experience and what to expect with GentleCure (Image-Guided SRT).
See more videos about the GentleCure (Image-Guided SRT) experience.
More than 66,000 patients have been successfully treated with GentleCure (Image-Guided SRT)
Patients report being satisfied with GentleCure (Image-Guided SRT). In a survey of more than 12,000 patients who completed treatment, 99.9% reported being happy with their treatment decision and said they would recommend GentleCure (Image-Guided SRT) to others.
Visit GentleCure.com/Patient Stories to hear from some of them.
GentleCure (Image-Guided SRT) has a proven track record that is backed by science and clinical research
At Grafton Dermatology and Cosmetic Surgery, our team of dermatologists reviewed the published research and here is what we found:
Clinically proven
2021;9(1):153-166.
Retrospective chart review
evaluating LC rates of 1632
patients with 2917 stage 0-II
carcinomas
- In 2021, chart reviews were conducted for 1632 patients who had Image-Guided SRT to treat one or more early-stage basal or squamous cell skin cancers. Of those patients, 2917 skin cancers in total were treated. The results showed a 99.3% cure rate with Image-Guided SRT, which we believe to be equal to or better than Mohs surgery.
- In 2022 and 2023, additional studies were published that showed the efficacy and safety of Image-Guided SRT to be superior to non-image-guided forms of radiation therapy across skin cancer types—confirming its use as a first-line treatment for basal and squamous cell skin cancers. This means doctors and patients should give equal consideration to Mohs surgery and surgery-free Image-Guided SRT as standards of care.
More information about the published research supporting the use of GentleCure (Image-Guided SRT) can be found here.
Why we chose to offer GentleCure (Image-Guided SRT)
There are several different radiation-based treatments available for skin cancer. But the safety, cure rates, and cosmetic outcomes vary based on the treatment technology and clinical protocols used. We chose GentleCure (ImageGuided SRT) because it is the only skin cancer treatment with advanced imaging that lets us see and measure the cancer and adapt the dose to precisely what you need at each stage of treatment. It has also been shown to be the safest and most effective of all radiation-based treatments for skin cancer with superior cosmetic results.
If you are considering radiation therapy to treat your skin cancer, make sure you are getting GentleCure (ImageGuided SRT) with adaptive radiotherapy protocols. It’s the safe, effective, and gentle way to treat skin cancer using the most advance treatment technology available today.
Treatment results – Seeing is believing!
SIMULATION
BEFORE TREATMENT
MID-TREATMENT
DURING TREATMENT
2-WEEK FOLLOW-UP
AFTER TREATMENT
GentleCure (Image-Guided SRT) is covered by Medicare and most health insurance plans
Side effects and cosmetic results
When X-ray energy is used to kill cancer cells, your body will replace the dead cancer cells with healthy tissue over time. There is no surgical scarring and no need for reconstructive surgery. There is, however, a small risk of skin atrophy (thinning of the skin) and pigment changes (changes in the color of the skin) at the treatment site. Other potential side effects may include skin inflammation with redness and swelling at the treatment site. Topical creams or ointments can be used over the course of treatment to minimize these side effects, and the side effects usually go away 2-to 6-weeks after treatment is complete. There is also a risk of alopecia (hair loss) in the treated area only.
In the 7 years that patients have been receiving GentleCure (Image-Guided SRT), there have been NO reported cases of secondary skin cancers occuring as a result of treatment.
The skin cancer treatment team at GentleCure
Lee Grafton, MD
Tamela L. Charbonnet, MD
Kristal B. Guidroz, MD
Monique E. Blanchard, MPAS, PA-C
Denton “Luke” Paige, PA
Elizabeth Arceneaux, FNP
Ariel Lanegrasse, R.T. (R)(T)
GentleCure is proud to offer the non-surgical, gold-standard for the treatment of nonmelanoma skin cancer
Grafton Dermatology
Grafton Dermatology and Cosmetic Surgery is a team of dedicated, board-certified physicians and caring professionals.
Service Areas
Serving Terrebonne, Lafourche, Assumption, St. Mary, St. James, St. John the Baptist, and St. Charles Parishes using the latest in dermatological breakthroughs.